Sugar Lakes Family Practice

Sugar Land, Texas 77479

1 studies enrolling now · 10 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, COVID-19, Cardiovascular Disease, Diabetes Mellitus, Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease, Hypercholesteremia, Migraine, Obesity, Overweight, SARS-CoV-2 Infection

Studies at this site

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD — Completed
• Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight — Running, not enrolling
• A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine — Completed
• Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity — Stopped early
• Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting — Stopped early
• A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early